Atara: EMA Grants Accelerated Assessment To Tab-cel - Quick Facts

Atara Biotherapeutics, Inc. (ATRA) said the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted accelerated assessment to the company's lead product candidate, tabelecleucel, for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease.

Atara said MAA for tab-cel is on track for submission in November 2021. The company expects a decision regarding approval in the second half of 2022.

Tab-cel also has Orphan Drug status in Europe. It was previously granted PRIME designation by the EMA.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Creminelli Fine Meats is recalling around 4,207 pounds of ready-to-eat or RTE parmesan salami sticks citing misbranding and an undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves 2.6-oz. plastic pouches containing "CREMINELLI FINE MEATS salami minis UNCURED ITALIAN SALAMI PARMESAN" with "BES The U.S. Food and Drug Administration is proposing a rule that will broaden the range of nonprescription or over-the counter drugs available to consumers. The rule titled, "Nonprescription Drug Product with an Additional Condition for Nonprescription Use," is intended to increase options for the development of safe and effective nonprescription drugs. The U.S. Food and Drug Administration announced that Australian organic infant formula and baby food producer, Bellamy's Organic, has agreed to send around 696,000 cans of general formula milk to the United States to meet the supply shortage. Under the FDA's enforcement discretion to source more infant formula to the U.S., the available Bellamy's Organic products include about 1.4 million pounds.
Follow RTT